ProofPilot Strengthens Advisory Board with Michelle Everill's Expertise
ProofPilot is making strides in transforming the clinical trial landscape by welcoming Michelle Everill, a distinguished expert in clinical operations and patient recruitment, to its Strategic Advisory Board. With over 20 years of experience at prominent organizations such as Bristol Myers Squibb and Pfizer, her extensive knowledge is poised to significantly influence the growth of the platform.
Michelle Everill's Professional Background
Prior to her role at ProofPilot, Michelle held the position of VP of Global Trial Optimization at a leading biotechnology firm. In this capacity, she excelled in areas like data analytics, clinical operations, and feasibility strategy. Her impressive career features various leadership roles where she developed her expertise in enhancing trial performance while implementing cost-saving measures, making her an ideal addition to ProofPilot.
Strategic Contributions
As a new member of the Strategic Advisory Board, Michelle will provide insights on product direction and strategic initiatives designed to enhance the experiences of patients, sites, and study teams involved in clinical trials. Her expertise is expected to guide the company towards innovative solutions that meet the changing demands of the industry.
ProofPilot's Dedication to Innovation
Through its Clinical Experience Platform, ProofPilot is committed to modernizing clinical trials by improving communication among sponsors, patients, and study sites. The addition of Michelle is seen as a vital step in reinforcing the company's mission to deliver valuable outcomes for all stakeholders involved.
Michelle's Vision for Clinical Trials
Michelle has shared her excitement about joining ProofPilot, recognizing the transformative potential of the company's platform. She is eager to leverage her expertise to advance clinical research. Her dedication to enhancing the experiences of both patients and study teams aligns perfectly with ProofPilot’s overarching mission.
About ProofPilot
Leading the way in clinical trial innovation, ProofPilot employs its Clinical Experience Platform to streamline communication processes in clinical research. Known as StudyCoPilot, this platform centralizes interactions among all parties involved, which is essential for boosting efficiency and ensuring the success of trials. For more details, visit https://www.proofpilot.com.
Frequently Asked Questions
What is ProofPilot's main focus?
ProofPilot’s primary goal is to improve the clinical trial process by centralizing communication for all stakeholders involved.
Who is Michelle Everill?
Michelle Everill is a seasoned professional in clinical operations, having previously served as VP of Global Trial Optimization at Alnylam Pharmaceuticals.
What role will Michelle play on the advisory board?
Michelle will offer guidance on product direction and strategic initiatives to enhance the experiences of those involved in clinical trials.
How does ProofPilot ensure the effectiveness of its platform?
ProofPilot continually enhances its platform by integrating feedback from industry experts like Michelle Everill, allowing it to adapt to the evolving clinical trial landscape.
Where can I find more information about ProofPilot?
To learn more about ProofPilot and its offerings, visit their official website at https://www.proofpilot.com.